# DeepLook Medical

> DeepLook Medical is a Scottsdale, Arizona medical imaging company whose FDA-cleared software, DL Precise, helps radiologists see and measure suspicious lesions that hide inside dense breast tissue. Using proprietary shape-recognition algorithms that overlay directly on existing imaging systems, the tool delivers single-click segmentation across mammography, ultrasound, CT and MRI. Led by CEO Marissa Fayer, the company is in commercial use at major U.S. health systems and closed a Series A led by Xcellerant Ventures in 2024.

- **Founded:** 2019
- **Headquarters:** Scottsdale, Arizona, United States
- **Founders:** Marissa Fayer (CEO (joined as advisor 2020, CEO since 2022))
- **Team size:** ~18 employees
- **Products:** DL Precise
- **Notable:** FDA 510(k) clearance for DL Precise in 2021 for one-click segmentation and measurement across imaging modalities, Commercial deployment at Cleveland Clinic, Mayo Clinic, AdventHealth and Geisinger, Documented 12% improvement in recall performance at a New York metropolitan hospital, aligned with ACR guidelines

## Products & services

- **DL Precise** — FDA 510(k)-cleared imaging software (cleared July 9, 2021) that provides one-click segmentation and enhanced visualization of suspicious lesions and tumor morphology. Uses proprietary deterministic shape-recognition algorithms, overlays on existing radiology workstations, and works across mammography, ultrasound, CT and MRI - with a particular strength in dense breast tissue.

## Achievements

- FDA 510(k) clearance for DL Precise in 2021 for one-click segmentation and measurement across imaging modalities
- Commercial deployment at Cleveland Clinic, Mayo Clinic, AdventHealth and Geisinger
- Documented 12% improvement in recall performance at a New York metropolitan hospital, aligned with ACR guidelines
- Contributed to detection of a previously undiagnosed cancer in real-world use
- Closed Series A led by Xcellerant Ventures in 2024

## Latest updates

- **2024-09** — Announced first close of Series A funding led by Xcellerant Ventures with support from OKG Capital, alongside promising cancer-detection data.
- **2025-05** — Confirmed DL Precise is in commercial use at major U.S. healthcare institutions and expanding into broader ultrasound applications, with studies running in the U.S., U.K. and Israel.

## Links

- Website: https://deeplookmedical.com
- LinkedIn: https://www.linkedin.com/company/deeplookmedical

---

Profile page: https://yespress.io/deeplook-medical
Published by YesPress — https://yespress.io
Last updated: 2026-06-07